Zevra Therapeutics (ZVRA) Non-Current Assets (2014 - 2026)
Zevra Therapeutics' Non-Current Assets came in at $87.74 million for Q3 2026, up 95.0% from $45 million a year earlier and up 70.7% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Non-Current Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Non-Current Assets was $61.72 million, down 33.0% from FY2024.
- Non-Current Assets carries a five-year compound annual growth rate of 85.3% (FY2020 to FY2025).
- Going back by year, Non-Current Assets was $92.1 million in FY2024 (+7.9%), $85.39 million in FY2023 (+279.4%), $22.51 million in FY2022 (+25.8%) and $17.89 million in FY2021 (+532.6%).
- The Q3 2026 figure represents the highest quarterly Non-Current Assets since Q1 2025.
- Year-over-year, Non-Current Assets increased in four of the last eight quarters, with an average decline of 2.2%.
- The fastest year-over-year change in Non-Current Assets over five years came in Q1 2022 (growth of 636.4%), and the weakest in Q2 2023 (a decline of 94.3%).
- Business Quant data shows ZVRA's Non-Current Assets at $51.41 million (Q2 2026), $48.61 million (Q1 2026) and $61.72 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 87.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 87.74 Mn |
| Jun 30, 2026 | 51.41 Mn |
| Mar 31, 2026 | 48.61 Mn |
| Dec 31, 2025 | 61.72 Mn |
| Sep 30, 2025 | 45.00 Mn |
| Jun 30, 2025 | 29.94 Mn |
| Mar 31, 2025 | 91.14 Mn |
| Dec 31, 2024 | 92.10 Mn |
| Sep 30, 2024 | 92.11 Mn |
| Jun 30, 2024 | 83.52 Mn |
| Mar 31, 2024 | 88.39 Mn |
| Dec 31, 2023 | 85.39 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 2.09 Mn |
| Mar 31, 2023 | 2.32 Mn |
| Dec 31, 2022 | 22.51 Mn |
| Sep 30, 2022 | 34.42 Mn |
| Jun 30, 2022 | 36.82 Mn |
| Mar 31, 2022 | 19.93 Mn |
| Dec 31, 2021 | 17.89 Mn |
API Access
Zevra Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();